DK0828494T3 - Fremgangsmåde til behandling af kognitiv dysfunktion - Google Patents
Fremgangsmåde til behandling af kognitiv dysfunktionInfo
- Publication number
- DK0828494T3 DK0828494T3 DK95922148T DK95922148T DK0828494T3 DK 0828494 T3 DK0828494 T3 DK 0828494T3 DK 95922148 T DK95922148 T DK 95922148T DK 95922148 T DK95922148 T DK 95922148T DK 0828494 T3 DK0828494 T3 DK 0828494T3
- Authority
- DK
- Denmark
- Prior art keywords
- cognitive dysfunction
- treatment
- methyl
- benzodiazepine
- thieno
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Steroid Compounds (AREA)
- Percussion Or Vibration Massage (AREA)
- Processing Of Meat And Fish (AREA)
- Pretreatment Of Seeds And Plants (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Radiation-Therapy Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Light Receiving Elements (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1995/006859 WO1996038151A1 (fr) | 1995-05-30 | 1995-05-30 | Procede de traitement du dysfonctionnement cognitif |
| CA002219902A CA2219902A1 (fr) | 1995-05-30 | 1995-05-30 | Utilisation du 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno¬2,3b|¬1,5|benzodiazepine pour le traitement du dysfonctionnement cognitif |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0828494T3 true DK0828494T3 (da) | 2002-09-02 |
Family
ID=25679786
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95922148T DK0828494T3 (da) | 1995-05-30 | 1995-05-30 | Fremgangsmåde til behandling af kognitiv dysfunktion |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0828494B1 (fr) |
| JP (1) | JPH11506096A (fr) |
| AT (1) | ATE220550T1 (fr) |
| AU (1) | AU707858B2 (fr) |
| CZ (1) | CZ292565B6 (fr) |
| DE (1) | DE69527442T2 (fr) |
| DK (1) | DK0828494T3 (fr) |
| ES (1) | ES2180643T3 (fr) |
| FI (1) | FI973987A0 (fr) |
| HK (1) | HK1009393A1 (fr) |
| HU (1) | HUT77907A (fr) |
| MX (1) | MX9707936A (fr) |
| NO (1) | NO318553B1 (fr) |
| NZ (1) | NZ288037A (fr) |
| PL (1) | PL189714B1 (fr) |
| PT (1) | PT828494E (fr) |
| WO (1) | WO1996038151A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3274579B2 (ja) * | 1995-01-12 | 2002-04-15 | 住友製薬株式会社 | 脳血管障害に伴う精神症候治療剤 |
| UA57727C2 (uk) * | 1996-03-11 | 2003-07-15 | Елі Ліллі Енд Компані | Спосіб лікування надмірної агресивності |
| PL196814B1 (pl) | 2002-05-17 | 2008-02-29 | Inst Farmaceutyczny | Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty |
| EP1709053B1 (fr) | 2004-01-27 | 2011-04-06 | Synthon B.V. | Sels stables d'olanzapine |
| SI1838716T1 (sl) | 2005-01-05 | 2011-10-28 | Lilly Co Eli | Olanzapin pamoat dihidrat |
| PL381564A1 (pl) | 2007-01-22 | 2008-08-04 | Koźluk Tomasz Nobilus Ent | Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5270464A (en) * | 1989-03-14 | 1993-12-14 | Janssen Pharmaceutica N.V. | Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones |
| GB9009229D0 (en) * | 1990-04-25 | 1990-06-20 | Lilly Industries Ltd | Pharmaceutical compounds |
-
1995
- 1995-05-30 NZ NZ288037A patent/NZ288037A/en unknown
- 1995-05-30 PT PT95922148T patent/PT828494E/pt unknown
- 1995-05-30 AT AT95922148T patent/ATE220550T1/de not_active IP Right Cessation
- 1995-05-30 EP EP95922148A patent/EP0828494B1/fr not_active Expired - Lifetime
- 1995-05-30 AU AU26936/95A patent/AU707858B2/en not_active Ceased
- 1995-05-30 CZ CZ19973243A patent/CZ292565B6/cs not_active IP Right Cessation
- 1995-05-30 MX MX9707936A patent/MX9707936A/es not_active IP Right Cessation
- 1995-05-30 WO PCT/US1995/006859 patent/WO1996038151A1/fr active IP Right Grant
- 1995-05-30 JP JP8536420A patent/JPH11506096A/ja active Pending
- 1995-05-30 DK DK95922148T patent/DK0828494T3/da active
- 1995-05-30 ES ES95922148T patent/ES2180643T3/es not_active Expired - Lifetime
- 1995-05-30 DE DE69527442T patent/DE69527442T2/de not_active Expired - Fee Related
- 1995-05-30 PL PL95323785A patent/PL189714B1/pl not_active IP Right Cessation
- 1995-05-30 HU HU9801173A patent/HUT77907A/hu not_active Application Discontinuation
-
1997
- 1997-10-15 NO NO19974766A patent/NO318553B1/no unknown
- 1997-10-17 FI FI973987A patent/FI973987A0/fi not_active IP Right Cessation
-
1998
- 1998-08-26 HK HK98110242A patent/HK1009393A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11506096A (ja) | 1999-06-02 |
| EP0828494A1 (fr) | 1998-03-18 |
| EP0828494B1 (fr) | 2002-07-17 |
| FI973987A (fi) | 1997-10-17 |
| FI973987A0 (fi) | 1997-10-17 |
| HK1009393A1 (en) | 1999-06-04 |
| ES2180643T3 (es) | 2003-02-16 |
| ATE220550T1 (de) | 2002-08-15 |
| WO1996038151A1 (fr) | 1996-12-05 |
| AU707858B2 (en) | 1999-07-22 |
| MX9707936A (es) | 1997-12-31 |
| NZ288037A (en) | 1999-09-29 |
| HUT77907A (hu) | 1998-10-28 |
| PL323785A1 (en) | 1998-04-27 |
| NO974766D0 (no) | 1997-10-15 |
| CZ292565B6 (cs) | 2003-10-15 |
| AU2693695A (en) | 1996-12-18 |
| EP0828494A4 (fr) | 1999-11-24 |
| PT828494E (pt) | 2002-10-31 |
| DE69527442D1 (de) | 2002-08-22 |
| PL189714B1 (pl) | 2005-09-30 |
| NO318553B1 (no) | 2005-04-11 |
| CZ324397A3 (cs) | 1998-08-12 |
| NO974766L (no) | 1997-12-09 |
| DE69527442T2 (de) | 2003-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY114701A (en) | Process and crystal forms of 2-methyl-thieno- benzodiazepine | |
| ATE500258T1 (de) | Verfahren zur herstellung von olanzapin form i | |
| ZA963098B (en) | Method for treating dyskinesias. | |
| NZ510208A (en) | Olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine) pamoate salt | |
| DK0828494T3 (da) | Fremgangsmåde til behandling af kognitiv dysfunktion | |
| ZA971566B (en) | Method of treating leather with pmphoteric polymers. | |
| DK0733634T3 (da) | Fremgangsmåde til fremstilling af et thieno(2,3-b) (1,5)benzodiazepinderivat | |
| NZ332037A (en) | Olanzapine for treating migraine pain | |
| TW429149B (en) | Pharmaceutical composition for treating conditions resulting from the cessation and withdrawal from the use of nicotine | |
| DK0773192T3 (da) | Fremgangsmåde til behandling af selenholdigt spildevand | |
| IL128028A0 (en) | Treatment of psychotic disorders | |
| DK0831835T3 (da) | Behandling af anorexia | |
| FI980091A (fi) | Menetelmä ylijäämäaktiivilietteen käsittelemiseksi | |
| DK0877818T3 (da) | Fremgangsmåde til aktivering af en kinase | |
| HUP9902882A2 (hu) | Olanzapin alkalmazása álmatlanság kezelésére szolgáló gyógyszerkészítmények előállítására | |
| ZA966936B (en) | Process for the treatment of water. | |
| ES1033530Y (es) | Aparato para depurar aguas residuales. | |
| ZA966815B (en) | Method of treating water. | |
| ZA963472B (en) | Method of treatment. | |
| ZA991836B (en) | Method of treating sewage. |